The Escherichia coli hemA gene, essential for the synthesis of 5-aminolevulinic acid (ALA), was isolated and sequenced. The following criteria identified the cloned gene as hemA. (i) The gene complemented a hemA mutation of E. coli. (ii) The gene was localized to approximately 26.7 min on the E. coli chromosomal linkage map, consistent with the location of the mapped hemA locus. Furthermore, DNA sequence analysis established that the cloned gene lay directly upstream of prfA, which encodes polypeptide chain release factor 1. (iii) Deletion of the gene resulted in a concomitant requirement for ALA. The hemA gene directed the synthesis of a 46-kilodalton polypeptide in maxicell experiments, as predicted by the coding sequence. The DNA and deduced amino acid sequences of the E. coli hemA gene displayed no detectable similarity to the ALA synthase sequences which have been characterized from a variety of organisms, but are very similar to the cloned Salmonella typhimurium hemA sequences (T. Elliott, personal communication). Results of S1 nuclease protection experiments showed that the hemA mRNA appeared to have two different 5' ends and that a nonoverlapping divergent transcript was present upstream of the putative distal hemA transcriptional start site.
The prosthetic groups of cytochromes, catalase, peroxidases, siroheme, and vitamin B12, as well as active components of chlorophyll and bacteriochlorophyll molecules in photosynthetic organisms, are formed from tetrapyrrole derivatives. The first committed precursor of the common tetrapyrrole biosynthetic pathway is 5-aminolevulinic acid (ALA), which can be synthesized via two dissimilar routes. In one pathway, the condensation of succinyl-coenzyme A and glycine to form ALA is catalyzed by ALA synthase (EC 2.3.1.37). Genes which encode ALA synthase have been isolated from a number of procaryotic and eucaryotic organisms (6, 9, 10, 17, 24, 27, 30, 44, 46, 49) , and based on sequence similarity, the enzyme displays significant evolutionary conservation (6, 32) . A second pathway, in which ALA is derived from the intact 5-carbon skeleton of glutamate in a multienzymatic process requiring tRNAGIU, exists in plant chloroplasts, Chlamydomonas reinhardtii, Euglena gracilis, cyanobacteria, and an anaerobic archaebacterium, Methanobacterium therinoautotrophicium (for review, see reference 22). To our knowledge, genes which encode the component enzymes of this pathway have not been cloned.
The focus of this investigation is the molecular characterization of ALA biosynthesis in Escherichia coli. Mutations of E. coli which cause a defect in ALA synthesis and therefore result in ALA auxotrophy under nonfermentative growth conditions have been isolated and mapped to two different loci on the linkage map, the hemA and popC loci at approximately 27 and 4 min, respectively (37, 43) . hemA mutants were characterized initially as respiration deficient, small-colony variants that lack catalase and cytochromes due to their inability to synthesize heme (42) . We describe in this paper the isolation and DNA sequencing of the hemA gene from E. coli and the preliminary characterization of its product. We also report a preliminary investigation into the putative hemA open reading frame (ORFA in Fig. 1 ). Approximately 2 pLg of this plasmid was digested with HindlIl and transformed into E. coli JC7623 (Table 1) . Transformants were selected on LB containing kanamycin and ALA and tested for the absence of the ampicillin resistance marker present on vector sequences and for ALA auxotrophy. Nucleic acid methods. Southern hybridizations, small-scale and large-scale isolations of plasmid DNA, and genomic DNA preparations were performed according to described procedures (3). RNA was isolated by a CsCl gradient method as described before (2) .
Bal31 exonuclease was used to generate a series of overlapping deletions spanning the DNA fragment to be sequenced (36) . The appropriate DNA fragments were then cloned into M13mpl8 or M13mpl9 (50) with the Bal31-deleted end inserted nearest the primer-binding site in the lacZ coding sequence. Single-stranded DNA template was prepared in JM103 (33, 34) and sequenced by the method of Sanger et al. (41) . The nucleotide sequence of both strands was determined at least once. Materials and enzymes used for sequencing were purchased from either Bethesda Research Laboratories or United States Biochemical Corporation and used according to the supplier's recommendations. End-labeled probes used in S1 protocols were sequenced by the method of Maxam and Gilbert (31) .
The method of Berk and Sharp (8) as modified by Adams and Chelm (2) was used to map the 5' end of the hemA mRNA. For initial mapping, a 447-bp SalI-BstNI fragment that includes 144 bp of the hemA coding sequence and 303 bp of upstream sequence was isolated from a polyacrylamide gel, treated with calf intestinal alkaline phosphatase, and then 5'-end labeled with [_y-32P]ATP by using T4 polynucleotide kinase. Single-stranded labeled fragments were separated on an 8% denaturing polyacrylamide gel, isolated, and hybridized to RNA by the procedures referenced above.
For better resolution of the 5' end of the hemA transcript, a hemA-specific single-stranded DNA probe was synthesized by a primer extension method described by Adams 
Nucleotide sequence of the hemnA gene and the predicted amino acid sequence of the hemA polypeptide. The sequence of each DNA strand is shown for the region that separates hemA from the putative translational start site of the divergent ORFD. The proposed transcriptional start sites of the two major hemA RNA species are indicated by asterisks, and sequences which constitute possible promoter elements are underlined. The likely promoter sequences of the divergent ORFD transcript are underscored with dashed lines, and arrows indicate the nucleotides which correspond to the 5' end of the ORFD transcript. The nucleotide sequence which corresponds to the reverse complement of the synthetic oligonucleotide used for high-resolution Si mapping of the hlemA transcript is bracketed. This sequence has been deposited in the EMBL/GenBank data base (accession no. M25323).
Chelm (1) . A synthetic oligonucleotide, 5'-ACGATACACG TTCTCGC-3' (Fig. 2) , was labeled at its 5 (29) and for the measurement of enzyme activity. ALA synthase assays were also performed by the method of Burnham (12) as modified by Tai et al. (46) .
RESULTS
Isolation of the hemA gene. Two schemes were devised to isolate the hemA gene on a cosmid vector. The first approach was the complementation of the hemA mutation in SASX41B with a cosmid gene bank prepared from E. coli CR63. The second strategy was to clone a TnlO tetracycline resistance marker that was inserted adjacent to hemA on the E. coli chromosome in strain ORN125. We reasoned that some of the transformants which harbored TnlO on a recombinant cosmid would also contain hemA. The desired J. BACTERIOL.
on November 6, 2017 by guest http://jb.asm.org/ Downloaded from cosmids were isolated as described in Materials and Methods; one cosmid obtained by the first screen (pMRC2) and two cosmids isolated from the second (pMRC5 and pMRC10) were characterized in detail. The apparent complementation of the hemA mutation by cosmid pMRC2 required that transformants be selected initially in the presence of exogenously added ALA. Transformants could then grow in the absence of ALA at rates comparable to the wild type, suggesting that recombination was required for complementation. This was confirmed by showing that the apparent complementation did not occur in strain EV10, a derivative of SASX41B made RecA-by P1 transduction from MC1024 (Table 1 ). In contrast, pMRC5 and pMRC10 complemented SASX41B with no requirement for prior selection in the presence of ALA or recombination function. Plasmid subclones of pMRC2 (pMR15) and pMRC10 (pMR57) were obtained (Fig. 1) , and these exhibited the complementation characteristics of the parent cosmids described above. The presence of common restriction enzyme sites between the plasmid subclones suggested, and Southern hybridization experiments verified, that the DNA sequences isolated by the two different schemes were homologous (data not shown). The plasmid pMR57 contained the recombinant DNA insert of pMR15, along with additional flanking DNA that appeared to be necessary for hemA activity.
DNA sequence analysis. DNA sequencing of the cloned insert containing the putative hemA gene revealed two large open reading frames (ORFs), herein designated A and B. These two ORFs, along with their coding capacity and direction of transcription, are shown schematically in Fig. 1 . Two other ORFs of undetermined lengths (ORFC and ORFD in Fig. 1 ) were also located in this region, but these have not been characterized further.
A computer search of GenBank sequences disclosed that ORFB corresponded to prfA, the gene that encodes peptide chain release factor 1 (RF1), which had been isolated and sequenced previously (14) . Since both prfA and hemA map to about 27 min on the genetic linkage map (26, 39, 43) , the cloned DNA sequences came from the hemA region of the chromosome. If ORFA corresponds to the hemA gene, it would explain why pMR15 does not, by itself, display hemA activity, since it lacks a portion of this ORF.
The coding sequence of the putative hemA gene, ORFA, and upstream and downstream flanking sequences are presented in Fig. 2 . Assuming that the coding region begins at the first ATG, ORFA could theoretically code for a polypeptide consisting of 418 amino acids with a molecular weight of 46,312. The 41-bp intergenic region separating the ORFA stop codon and the first codon of prfA are also presented in the figure.
Maxicell experiments. Maxicell labeling experiments were performed in order to determine whether ORFA produced a polypeptide of the anticipated size. A polypeptide of approximately 46 kilodaltons was synthesized by the plasmid pMR81 (Fig. 3) . No other ORFs were present on this plasmid which had a coding capacity sufficiently large to encode this polypeptide. Furthermore, an identical plasmid that was deleted for the 278-bp BglII fragment within ORFA (pMR81ABgl) failed to synthesize this polypeptide (Fig. 3) .
These experiments showed that ORFA can direct the synthesis of a polypeptide of a size in agreement with that predicted by the DNA coding sequence.
Construction (Fig. 1) . The nptII probe hybridized to a 5.2-kpb EcoRI fragment of DNA derived from the mutant but did not hybridize to DNA isolated from the parent strain (Fig. 4,  lanes 1 and 2) (Fig. 4, lanes 3 and 4) ALA synthase assays. Extracts from various strains of E. coli, including strains which harbored the putative hemA gene on high-copy-number plasmids, were tested for ALA synthase activity by the protocols described in Materials and Methods. We were unable to detect activity in any of these strains. However, ALA synthase activity could be readily demonstrated by these methods in an E. coli strain which contained the Bradyrhizobium japonic um hemA gene cloned into pUC9 (data not shown), indicating that the protocols were adequate for ALA synthase detection. Reports of ALA synthase activity in E. coli are inconsistent (44, 46) , and recent experiments indicate that ALA is synthesized by the 5-carbon glutamate route in E. coli (see below). Additional experiments are required to resolve this question. Electrophoresis of each of the protected products resulting from Si nuclease experiments adjacent to a MaxamGilbert sequencing ladder generated from its corresponding full-length probe enabled identification of the 5' end points of the presumptive transcriptional start sites (data not shown). Results of high-resolution SI nuclease mapping of the hemA transcript are presented in Fig. 6 . The nucleotides which correspond to the 5' ends of the hemA message and the divergent ORFD transcript are indicated in Fig. 2 . The 5' ends of the hemA transcript were separated by 92 nucleotides and were evident in each of four different RNA preparations and in experiments with several different probes ( Fig. 5 and 6 , and data not shown). It is therefore unlikely that they are due to artifacts associated with the Si j; r,. The apparent start sites of the distal hemA transcript and the ORFD transcript did not overlap, but were separated by approximately 45 nucleotides (Fig. 2) . Whether these sequences play a role in the regulation of either transcript has not yet been addressed experimentally. DISCUSSION We report in this investigation the isolation and DNA sequence of the hemA gene from E. coli. The cloned gene was identified as hemA based on the following results.
(i) The gene complemented the hemA mutation of SASX41B. The apparent complementation of the mutant hemA allele by truncated copies of the cloned gene required RecA function, indicating that the cloned DNA corresponded to hemA and eliminating the possibility that the cloned gene suppressed the mutant phenotype of SASX41B by a mechanism involving a different locus.
(ii) The gene was localized to approximately 26.7 min on the E. coli linkage map, the site mapped previously for the hemA locus. Sequence analysis of the cloned DNA disclosed that the hemA gene lay directly upstream of and was transcribed in the same direction as prfA, which encodes the RF1 protein and maps to 26.7 min. Transduction mapping with P1 also localized the cloned gene to the 27-min region of the chromosome, and in addition, the restriction map of the DNA sequence surrounding the isolated hemA gene corresponds to the chromosomal restriction map at 26.7 min (25) .
(iii) Inactivation of the chromosomal homolog of the cloned gene created an ALA auxotroph. Strain EV61 contained a defined insertion in the hemA gene that removed 278 nucleotides of the coding sequence. This strain was respiration deficient and lacked catalase activity, but formed small colonies on agar plates if provided with a fermentable carbon source. The mutant phenotype was completely reversible when the medium was supplemented with ALA. Thus, the hemA gene probably does not encode a polypeptide vital to the survival of E. coli, although the possibility that strain EV61 harbors a compensatory suppressor mutation or that some ALA is synthesized via an alternate pathway has not been ruled out by these experiments.
The inability to construct a gene replacement mutant in which the nptII cassette is transcribed in a direction opposite to that of hemA implies that this insertion may be polar on the downstream prfA gene. This effect may be less severe or absent when the nptII gene is transcribed in the same direction as prfA, perhaps because the nptII gene provides a new promoter for prfA. Attempts to create chromosomal deletions that extended into the prfA coding region were unsuccessful (data not shown), suggesting that REl is essential for the viability of E. coli. This would not be surprising in light of its role in polypeptide chain termination and also because prfB, which encodes peptide chain release factor 2 (RF2), is indispensable (23) . These observations, in conjunction with the inability to transduce the hemA insertion from EV61 into different backgrounds, suggest that some insertions in hemA may be polar on prfA. It is possible that EV61 possesses a secondary mutation that suppresses the polar effect on prfA expression.
The computer analysis program of Pustell and Kafatos (38) was used to compare the DNA and amino acid sequences of the E. coli hemA gene and ALA synthase sequences which had been reported from several organisms. The E. coli hemA sequence exhibited no significant similarities with the ALA synthase sequences of B. japonicum, chicken, mouse, or human (data not shown). This observation was unexpected, VOL. 171, 1989 on November 6, 2017 by guest http://jb.asm.org/ Downloaded from as substantial similarities exist between B. japonicum and chicken (30) , mouse, and human (our unpublished results) and among the various ALA synthase sequences of eucaryotic origin (6) . However, the E. coli hemA gene exhibits extensive similarities with the DNA and amino acid sequences of the cloned Salmonella tvphimiuriium hemA gene (T. Elliott, personal communication). The predicted amino acid sequences share 94.3% identical residues over the entire length of the polypeptides, and the amino acids are 96.9% conserved (data not shown).
This lack of similarity to cloned ALA synthase sequences, coupled with our inability to detect ALA synthase activity in E. coli cell extracts, suggested that the primary route of ALA synthesis in E. coli might not be via ALA synthase.
Interestingly, the B. japonicium hemA gene cloned into pUC9 complemented the E. coli hemA strain SASX41B. This result implies that ALA synthase can function in E. coli but does not prove that this is the usual means of ALA biosynthesis in this organism. A recent report (28) presents convincing evidence that the 5-carbon glutamate pathway operates in E. coli, which would be consistent with our results and which would suggest that the hemA gene may code for one of the enzymes involved in this pathway.
The results of Si nuclease protection experiments suggest that transcription of the hemA message may initiate at two different sites or, alternatively, that there may be a processing event at the 5' nontranslated end of the message. Two protected fragments of different sizes were apparent when experiments were performed with RNA samples isolated from cells grown under several different cultural conditions with respect to carbon substrate and anaerobicity. It will now be possible to examine whether transcription of hemA is regulated under various growth conditions and whether hemA expression plays a role in the regulation of heme biosynthesis.
Nucleotides upstream of each of the transcriptional start sites can be identified that display similarity to the canonical -10 and -35 sequences of E. coli o7) consensus promoter elements (20) (Fig. 2 ). For hemAI, two different hexanucleotides are denoted in Fig. 2 that show similarity to the -35 promoter element. Although the sequence proximal to hemAl is better matched to the consensus, it is not spaced appropriately with respect to the -10 element and thus may not function with the designated -10 element as an RNA polymerase-binding site. Whether these or other sequences constitute functional promoters has not been addressed in this study. Regions of divergent transcription are common in E. coli, and in many cases the product of one transcript plays a regulatory role in the level of expression of transcripts that originate in the region (7) . The possibility that ORFD could play a role in the level of hemA mRNA therefore warrants investigation.
A 41-bp region separates the stop codon of the hemA ORF from the start codon of the prfA gene. Interestingly, the stop codon of the hemA gene is recognized specifically by RF1 (14) , but whether this observation is of any functional significance has not been determined. A putative promoter sequence for the prfA gene was identified by Craigen et al. (14) in what we have shown is the COOH-terminal region of the hemA coding sequence. There has been no demonstration that the sequence serves as a functional promoter, and it has not been determined directly whether the expression of the two genes is coordinated in any manner.
In summary, we have presented evidence that the hemA gene from E. coli encodes a polypeptide which functions in the synthesis of ALA but which shows no similarity to cloned ALA synthase sequences. We were unsuccessful in detecting ALA 
